About the program: Project Equity is a 2021 initiative launched by the FDA's Oncology Center of Excellence to ensure that ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
In the final days of the Biden Administration, the United States Food and Drug Administration (FDA) finalized the guidance on ...
On January 7, the U.S. Food and Drug Administration (FDA) finalized its October 2023 guidance document titled “Communications From Firms to ...
W ith respiratory-disease season in full swing and a bird flu outbreak rapidly evolving, the new Trump Administration has ...
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...
The FDA needs to strengthen guardrails to ensure its accelerated approval pathway is used appropriately, the HHS Office of ...
FDA recently issued two draft guidance documents discussing: (1) the use of artificial intelligence (AI) to produce information to support ...
The U.S. Food and Drug Administration hopes "front-of-package" labeling will better improve the American population's health, ...
GoodRx is monitoring seven potential FDA drug approvals in 2025, including a possible expanded label for Ozempic. Here are this year's most anticipated approval decisions, according to a GoodRx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback